

A robust, simple solution for sealing & disposing of all 96 extraction tubes
Specification
| 7-50x continuous zoom stereo microscope | XTL-205A | XTL-205B | XTL-204A | XTL-2048 | XTL-203A | XTL-203B | |
| Zoom Body | Binocular head,45°decline,360°rotate | ● | ● | ● | |||
| Trinocular head,45°decline,360*rotate | ● | ● | ● | ||||
| Eyepiece | WF10X22mm | ● | ● | ● | ● | ● | ● |
| Objective | zoom objective 0.7X—5X | ● | ● | ● | ● | ● | ● |
| Zoom Rate | 0.1:07.1 | ● | ● | ● | ● | ● | ● |
| Total Amplific- ation Rate | the standard configuration is 7X-50X | ● | ● | ● | ● | ● | ● |
| Auxiliary Lens | 0.5X,0.7X,1X,1.5X,2X For Option | O | O | O | O | O | O |
| WorkingDistance | 100mm | ● | ● | ● | ● | ● | ● |
| Diopter | 55mm-75mm | ● | ● | ● | ● | ● | ● |
| Focus arm | 76mm Diameter,32mm pole size | ● | ● | ● | ● | ● | ● |
| Plate | Black/White plate,Glass plate for option | ● | ● | ● | ● | ● | ● |
| Optional | Stand | Q | Q | ||||
| Stand | BI3 base.column sunnort unner and ower light source 3 WLED | ● | ● | ||||
| BL3-A base vertical arm bracket upper and lower light source 3 WLED | ● | ● | |||||
| B3 base column support has no light source | ● | ● | |||||
| External light source | LED illumination | Q | Q | Q | O | ||
| Optiona | Photography,camera accessories CCD Coupler | o | o | o | o | o | o |
| Optional | Display attachment Monitor | ||||||
Name of Product
Fasciola hepatica – IgG ELISA
Catalog Number
AF 9650
Short Info
Fasciolosis is one of the most frequently encountered autochthonous helminthic infections in Central Europe. The immunodiagnosis of Fasciola hepatica infections is challenged by high serological cross-reacitivity with other (hepatic) parasitological infections encountered in Central Europe, such as alveolar echinococcosis, toxocarosis and ascariosis, but also other parasitic infections acquired during overseas travel. The SAP-2 recombinant antigen shows a high specificity, especially with patients with other parasitic infections. It is a suitable serological test for routine diagnosis of human fasciolosis, particularly if the results are supported by clinical history.
This product is manufactured by Bordier Affinity Products in Switzerland and distributed in Germany exclusively by Milenia Biotec.
Method/Platform
ELISA in microplate format
Range/Assay Sensivity
77% sensitivity, 98% specificity
Test Principle
The kit provides all the material needed to perform 96 enzyme-linked immunosorbant assays (ELISA) on breakable microtitration wells sensitized with Fasciola hepatica recombinant antigen. Specific antibodies in the sample will bind to the antigen and washing will remove unspecific antibodies. The presence of parasite specific antibodies is detected with a Protein A – alkaline phosphatase conjugate. A second washing step will remove unbound conjugate. Revealing bound antibodies is made by the addition of pNPP substrate which turns yellow in the presence of alkaline phosphatase. Color intensity is proportional to the amount of Fasciola hepatica specific antibodies in the sample. Potassium phosphate is added to stop the reaction. Absorbance at 405 nm is read using an ELISA microplate reader.The test can be performed with automatic systems, but this must be validated by the user.
Brief Instructions
Storage
2-8° C
Components
ELISA wells, dilution buffer, washing solution, control sera, conjugate, substrate solution, stopping solution
12 x 8 strips (96 tests)
Fasciolosis is one of the most frequently encountered autochthonous helminthic infections in Central Europe. The immunodiagnosis of Fasciola hepatica infections is challenged by high serological cross-reacitivity with other (hepatic) parasitological infections encountered in Central Europe, such as alveolar echinococcosis, toxocarosis and ascariosis, but also other parasitic infections acquired during overseas travel. The SAP-2 recombinant antigen shows a high specificity, especially with patients with other parasitic infections. It is a suitable serological test for routine diagnosis of human fasciolosis, particularly if the results are supported by clinical history.